These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 26201869
1. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt. Ye Y, Ge YM, Xiao MM, Guo LM, Li Q, Hao JQ, Da J, Hu WL, Zhang XD, Xu J, Zhang LJ. J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869 [Abstract] [Full Text] [Related]
2. Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells. Ye Y, Qian XY, Xiao MM, Shao YL, Guo LM, Liao DP, Da J, Zhang LJ, Xu J. Int J Mol Sci; 2017 Jan 22; 18(1):. PubMed ID: 28117748 [Abstract] [Full Text] [Related]
3. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W. Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650 [Abstract] [Full Text] [Related]
4. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways. Huang S, Jin A. J Cell Biochem; 2018 Feb 08; 119(2):2248-2257. PubMed ID: 28857346 [Abstract] [Full Text] [Related]
5. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. Huang Y, Zhang J, Hou L, Wang G, Liu H, Zhang R, Chen X, Zhu J. J Exp Clin Cancer Res; 2017 Dec 28; 36(1):194. PubMed ID: 29282102 [Abstract] [Full Text] [Related]
6. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells. Prasad NK. Int J Oncol; 2009 Jan 28; 34(1):97-105. PubMed ID: 19082482 [Abstract] [Full Text] [Related]
7. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. Wang Y, Keogh RJ, Hunter MG, Mitchell CA, Frey RS, Javaid K, Malik AB, Schurmans S, Tridandapani S, Marsh CB. J Immunol; 2004 Dec 01; 173(11):6820-30. PubMed ID: 15557176 [Abstract] [Full Text] [Related]
8. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin. Shi R, Yang Z, Liu W, Liu B, Xu Z, Zhang Z. Oncol Rep; 2014 Feb 01; 31(2):812-8. PubMed ID: 24297051 [Abstract] [Full Text] [Related]
9. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Wang L, Yin J, Wang X, Shao M, Duan F, Wu W, Peng P, Jin J, Tang Y, Ruan Y, Sun Y, Gu J. Gastroenterology; 2016 May 01; 150(5):1183-1195.e16. PubMed ID: 26855187 [Abstract] [Full Text] [Related]
10. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M. Endocrinology; 2003 Sep 01; 144(9):4204-14. PubMed ID: 12933696 [Abstract] [Full Text] [Related]
12. Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway. Wang L, Ouyang F, Liu X, Wu S, Wu HM, Xu Y, Wang B, Zhu J, Xu X, Zhang L. Oncotarget; 2016 Jan 26; 7(4):3791-805. PubMed ID: 26565812 [Abstract] [Full Text] [Related]
13. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer. Shi J, Qu Y, Li X, Sui F, Yao D, Yang Q, Shi B, Ji M, Hou P. Cell Death Dis; 2016 Oct 27; 7(10):e2442. PubMed ID: 27787520 [Abstract] [Full Text] [Related]
15. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer. Xu L, Xiang W, Yang J, Gao J, Wang X, Meng L, Ye K, Zhao XH, Zhang XD, Jin L, Ye Y. J Exp Clin Cancer Res; 2024 Jan 11; 43(1):17. PubMed ID: 38200519 [Abstract] [Full Text] [Related]